On the public citation graph
Kinase Drug Discovery – What’s Next in the Field?
0 signed · 428 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/emmm.200900058openalex-snapshot
Role of the WNK‐activated SPAK kinase in regulating blood pressure
inferredcites →https://doi.org/10.1016/0014-5793(95)00357-fopenalex-snapshot
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1
inferredcites →https://doi.org/10.1016/j.bmcl.2011.06.065openalex-snapshot
Discovery of indazoles as inhibitors of Tpl2 kinase
inferredcites →https://doi.org/10.1016/j.bmcl.2011.10.071openalex-snapshot
Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series
inferredcites →https://doi.org/10.1016/j.bmcl.2012.06.104openalex-snapshot
GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
inferredcites →https://doi.org/10.1016/j.ceb.2009.01.015openalex-snapshot
Targeting protein kinases for the development of anti-inflammatory drugs
inferredcites →https://doi.org/10.1016/j.neuron.2010.10.014openalex-snapshot
Genetic Analysis of Pathways to Parkinson Disease
inferredcites →https://doi.org/10.1016/j.sbi.2010.10.001openalex-snapshot
Pseudokinases-remnants of evolution or key allosteric regulators?
inferredcites →https://doi.org/10.1016/j.tcb.2006.07.003openalex-snapshot
Emerging roles of pseudokinases
inferredcites →https://doi.org/10.1016/s0076-6879(95)55031-3openalex-snapshot
[29] Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf
inferredcites →https://doi.org/10.1016/s1074-5521(99)80088-xopenalex-snapshot
Paradoxical activation of Raf by a novel Raf inhibitor
inferredcites →https://doi.org/10.1021/jm0611004openalex-snapshot
Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)
inferredcites →https://doi.org/10.1021/jm301020qopenalex-snapshot
Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
inferredcites →https://doi.org/10.1038/372739a0openalex-snapshot
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
inferredcites →https://doi.org/10.1038/emboj.2011.78openalex-snapshot
MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases
inferredcites →https://doi.org/10.1038/nchembio.538openalex-snapshot
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
inferredcites →https://doi.org/10.1038/ni.1644openalex-snapshot
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
inferredcites →https://doi.org/10.1038/sj.embor.7401048openalex-snapshot
Structural insights into the recognition of substrates and activators by the OSR1 kinase
inferredcites →https://doi.org/10.1042/an20090007openalex-snapshot
Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
inferredcites →https://doi.org/10.1042/bj20041140openalex-snapshot
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
inferredcites →https://doi.org/10.1042/bj20051180openalex-snapshot
The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases
inferredcites →https://doi.org/10.1042/bj20070209openalex-snapshot
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
inferredcites →https://doi.org/10.1042/bj20100483openalex-snapshot
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
inferredcites →https://doi.org/10.1042/bj20100784openalex-snapshot
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
inferredcites →https://doi.org/10.1073/pnas.0808358106openalex-snapshot
Whole-genome association study identifies STK39 as a hypertension susceptibility gene
inferredcites →https://doi.org/10.1073/pnas.1004676107openalex-snapshot
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
inferredcites →https://doi.org/10.1073/pnas.1203223109openalex-snapshot
Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations
inferredcites →https://doi.org/10.1073/pnas.1215450109openalex-snapshot
Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
inferredcites →https://doi.org/10.1074/jbc.270.46.27489openalex-snapshot
PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
inferredcites →https://doi.org/10.1074/jbc.m802623200openalex-snapshot
Use of Akt Inhibitor and a Drug-resistant Mutant Validates a Critical Role for Protein Kinase B/Akt in the Insulin-dependent Regulation of Glucose and System A Amino Acid Uptake
inferredcites →https://doi.org/10.1084/jem.20020281openalex-snapshot
Genetic Dissection of the Cellular Pathways and Signaling Mechanisms in Modeled Tumor Necrosis Factor–induced Crohn's-like Inflammatory Bowel Disease
inferredcites →https://doi.org/10.1084/jem.20042372openalex-snapshot
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
inferredcites →https://doi.org/10.1084/jem.20070628openalex-snapshot
Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity
inferredcites →https://doi.org/10.1093/hmg/ddr348openalex-snapshot
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
inferredcites →https://doi.org/10.1097/bor.0b013e32832e089eopenalex-snapshot
Type I interferon and lupus
inferredcites →https://doi.org/10.1124/jpet.110.166173openalex-snapshot
A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation
inferredcites →https://doi.org/10.1126/science.1062844openalex-snapshot
Human Hypertension Caused by Mutations in WNK Kinases
inferredcites →https://doi.org/10.1126/science.1178377openalex-snapshot
Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
inferredcites →https://doi.org/10.1128/mcb.01456-06openalex-snapshot
The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK
inferredcites →https://doi.org/10.1146/annurev.biochem.75.103004.142702openalex-snapshot
LKB1-Dependent Signaling Pathways
inferredcites →https://doi.org/10.1152/physrev.00011.2004openalex-snapshot
Molecular Physiology and Pathophysiology of Electroneutral Cation-Chloride Cotransporters
inferredcites →https://doi.org/10.1158/1535-7163.mct-09-1012openalex-snapshot
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
inferredcites →https://doi.org/10.1159/000339165openalex-snapshot
High-Frequency Variant p.T60M in NaCl Cotransporter and Blood Pressure Variability in Han Chinese
inferredcites →https://doi.org/10.1161/cir.0b013e31820a55f5openalex-snapshot
Forecasting the Future of Cardiovascular Disease in the United States
inferredcites →https://doi.org/10.1242/jcs.018671openalex-snapshot
TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages
inferredcites →https://doi.org/10.1242/jcs.025312openalex-snapshot
Activation of the thiazide-sensitive Na+-Cl– cotransporter by the WNK-regulated kinases SPAK and OSR1
inferredcites →https://doi.org/10.1242/jcs.029223openalex-snapshot
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway
inferredcites →https://doi.org/10.1242/jcs.084111openalex-snapshot
Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade
inferredcites →https://doi.org/10.1371/journal.pbio.1000017openalex-snapshot
Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition
inferredcites →https://doi.org/10.1371/journal.pbio.1000126openalex-snapshot
ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor
inferredcites →https://doi.org/10.1371/journal.pone.0012913openalex-snapshot
Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
inferredcites →https://doi.org/10.1681/asn.2009121295openalex-snapshot
SPAK-Knockout Mice Manifest Gitelman Syndrome and Impaired Vasoconstriction
inferredcites →https://doi.org/10.2174/156802609789007345openalex-snapshot
Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease
inferredcites →https://doi.org/10.2174/156802609789044407openalex-snapshot
IRAK-4 Inhibitors for Inflammation
inferredcites →https://doi.org/10.3324/haematol.2008.001271openalex-snapshot
Clinical relevance of JAK2 (V617F) mutant allele burden
inferredcites →https://doi.org/10.4049/jimmunol.177.3.1913openalex-snapshot
MAPKAP Kinase 2-Deficient Mice Are Resistant to Collagen-Induced Arthritis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4862454openalex-extracted
Capillary Electrophoresis-Based Protein Kinase Ck2 Inhibitor Testing
inferred← citeshttps://doi.org/10.1002/0471266949.bmc214.pub2openalex-snapshot
US FDA‐Approved Small‐Molecule Kinase Inhibitors for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/14356007.a05_001.pub3openalex-snapshot
Antineoplastic and Immunomodulating Agents (L)
inferred← citeshttps://doi.org/10.1002/14356007.a05_001.pub4openalex-snapshot
Antineoplastic and Immunomodulating Agents (L)
inferred← citeshttps://doi.org/10.1002/9781118778166.ch4openalex-snapshot
The Changing Face of Innovation in Drug Discovery
inferred← citeshttps://doi.org/10.1002/9781118819586.ch8openalex-snapshot
Medicinal Chemistry Strategies to Prevent Compound Attrition
inferred← citeshttps://doi.org/10.1002/9781394182862.ch6openalex-snapshot
Kinase Liabilities in Early Drug Discovery
inferred← citeshttps://doi.org/10.1002/9783527665211.ch7openalex-snapshot
Structure‐Based Design of Protein Kinase Inhibitors
inferred← citeshttps://doi.org/10.1002/9783527673643.ch18openalex-snapshot
Case Studies: Selective Inhibitors of Protein Kinases – Exploiting Demure Features
inferred← citeshttps://doi.org/10.1002/9783527677252.ch01openalex-snapshot
Medicinal Chemistry Approaches to Creating Targeted Medicines
inferred← citeshttps://doi.org/10.1002/9783527687503.ch2openalex-snapshot
FLiK and FLiP: Direct Binding Assays for the Identification of Stabilizers of Inactive Kinase and Phosphatase Conformations
inferred← citeshttps://doi.org/10.1002/ange.201502142openalex-snapshot
Kovalent‐allosterische Kinase‐Inhibitoren
inferred← citeshttps://doi.org/10.1002/ange.201706345openalex-snapshot
Kovalente Liganden zur Adressierung einer lipophilen Bindetasche in der MAPK p38α
inferred← citeshttps://doi.org/10.1002/ange.201804917openalex-snapshot
Eine ungewöhnliche intramolekulare Halogenbindung führt zu konformationeller Selektion
inferred← citeshttps://doi.org/10.1002/ange.202014047openalex-snapshot
An Affinity‐Based, Cysteine‐Specific ATP Analog for Kinase‐Catalyzed Crosslinking
inferred← citeshttps://doi.org/10.1002/anie.201502142openalex-snapshot
Covalent‐Allosteric Kinase Inhibitors
inferred← citeshttps://doi.org/10.1002/anie.201706345openalex-snapshot
Covalent Lipid Pocket Ligands Targeting p38α MAPK Mutants
inferred← citeshttps://doi.org/10.1002/anie.201804917openalex-snapshot
An Unusual Intramolecular Halogen Bond Guides Conformational Selection
inferred← citeshttps://doi.org/10.1002/anie.202014047openalex-snapshot
An Affinity‐Based, Cysteine‐Specific ATP Analog for Kinase‐Catalyzed Crosslinking
inferred← citeshttps://doi.org/10.1002/biot.201300196openalex-snapshot
Fluorescent biosensors for high throughput screening of protein kinase inhibitors
inferred← citeshttps://doi.org/10.1002/cam4.368openalex-snapshot
Ectokinases as novel cancer markers and drug targets in cancer therapy
inferred← citeshttps://doi.org/10.1002/chem.201503552openalex-snapshot
Addressing the Glycine‐Rich Loop of Protein Kinases by a Multi‐Facetted Interaction Network: Inhibition of PKA and a PKB Mimic
inferred← citeshttps://doi.org/10.1002/cmdc.201300571openalex-snapshot
Facile Identification of Dual FLT3–Aurora A Inhibitors: A Computer‐Guided Drug Design Approach
inferred← citeshttps://doi.org/10.1002/cmdc.201700180openalex-snapshot
Kinome‐Wide Profiling Prediction of Small Molecules
inferred← citeshttps://doi.org/10.1002/cmdc.201700425openalex-snapshot
WNK Signaling Inhibitors as Potential Antihypertensive Drugs
inferred← citeshttps://doi.org/10.1002/cmdc.201700663openalex-snapshot
Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase
inferred← citeshttps://doi.org/10.1002/cmdc.201800625openalex-snapshot
In silico Screening and Evaluation of Plasmodium falciparum Protein Kinase 5 (PK5) Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.201900521openalex-snapshot
Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships
inferred← citeshttps://doi.org/10.1002/cmdc.202000150openalex-snapshot
Targeting the Water Network in Cyclin G‐Associated Kinase (GAK) with 4‐Anilino‐quin(az)oline Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.202000658openalex-snapshot
Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
inferred← citeshttps://doi.org/10.1002/cmdc.202200161openalex-snapshot
Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**
inferred← citeshttps://doi.org/10.1002/cpch.72openalex-snapshot
Activity‐Based Kinome Profiling Using Chemical Proteomics and ATP Acyl Phosphates
inferred← citeshttps://doi.org/10.1002/cplu.201300299openalex-snapshot
Real‐Time Monitoring of the Dephosphorylating Activity of Protein Tyrosine Phosphatases Using Microarrays with 3‐Nitrophosphotyrosine Substrates
inferred← citeshttps://doi.org/10.1002/ddr.70336openalex-snapshot
Structure‐Based Identification and Synthesis of Benzimidazole Azo–Schiff Base Derivatives as Recommended CK2 and PIM‐1 Inhibitors
inferred← citeshttps://doi.org/10.1002/hbm.26001openalex-snapshot
Regional gene expression patterns are associated with task‐specific brain activation during reward and emotion processing measured with functional MRI
inferred← citeshttps://doi.org/10.1002/iub.2241openalex-snapshot
KinCon: Cell‐based recording of full‐length kinase conformations
inferred← citeshttps://doi.org/10.1002/jcb.30468openalex-snapshot
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1002/jim4.70021openalex-snapshot
Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives
inferred← citeshttps://doi.org/10.1002/pmic.201600018openalex-snapshot
Proteomics insights into DNA damage response and translating this knowledge to clinical strategies
inferred← citeshttps://doi.org/10.1002/pmic.202000140openalex-snapshot
Advances in quantitative high‐throughput phosphoproteomics with sample multiplexing
inferred← citeshttps://doi.org/10.1002/pro.4742openalex-snapshot
Promoting the activity of a receptor tyrosine phosphatase with a novel pH ‐responsive transmembrane agonist inhibits cancer‐associated phenotypes
inferred← citeshttps://doi.org/10.1002/slct.202403302openalex-snapshot
Identification of Potent CHK2 Inhibitors‐Modulators for Therapeutic Application in Cancer: A Machine Learning Integrated Fragment‐Based Drug Design Approach
inferred← citeshttps://doi.org/10.1007/978-1-0716-0434-2_12openalex-snapshot
Site-Specific Phosphorylation of PDZ Domains
inferred← citeshttps://doi.org/10.1007/978-1-0716-3569-8_9openalex-snapshot
Kinase-Catalyzed Biotinylation to Identify Phosphatase Substrates (K-BIPS)
inferred← citeshttps://doi.org/10.1007/978-1-0716-4502-4_12openalex-snapshot
CellEKT: A Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors - A Step-by-Step Guide
inferred← citeshttps://doi.org/10.1007/978-1-4939-2486-8_13openalex-snapshot
Fragment-Based Design of Kinase Inhibitors: A Practical Guide
inferred← citeshttps://doi.org/10.1007/978-1-4939-3073-9_3openalex-snapshot
Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy
inferred← citeshttps://doi.org/10.1007/978-1-4939-3073-9_4openalex-snapshot
Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase
inferred← citeshttps://doi.org/10.1007/978-1-4939-3649-6_13openalex-snapshot
Current Status of PTP-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/978-1-4939-3673-1_10openalex-snapshot
Screening for Inhibitors of Kinase Autophosphorylation
inferred← citeshttps://doi.org/10.1007/978-3-030-38062-5_5openalex-snapshot
Small Molecule Effectors of Myosin Function
inferred← citeshttps://doi.org/10.1007/978-3-030-48283-1_5openalex-snapshot
Developing Kinase Inhibitors Using Computer-Aided Drug Design Approaches
inferred← citeshttps://doi.org/10.1007/978-981-13-8719-7_11openalex-snapshot
Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors
inferred← citeshttps://doi.org/10.1007/s00018-013-1552-5openalex-snapshot
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential
inferred← citeshttps://doi.org/10.1007/s00018-014-1616-1openalex-snapshot
Discoidin domain receptors: a proteomic portrait
inferred← citeshttps://doi.org/10.1007/s00216-014-7707-xopenalex-snapshot
Conjugation-free, visual, and quantitative evaluation of inhibitors on protein tyrosine kinases and phosphatases with a luminescent Tb(III) complex
inferred← citeshttps://doi.org/10.1007/s00436-020-06731-2openalex-snapshot
Identification of Schistosoma japonicum GSK3β interacting partners by yeast two-hybrid screening and its role in parasite survival
inferred← citeshttps://doi.org/10.1007/s00775-015-1300-4openalex-snapshot
Inhibition of cyclin-dependent kinase CDK1 by oxindolimine ligands and corresponding copper and zinc complexes
inferred← citeshttps://doi.org/10.1007/s10822-013-9700-4openalex-snapshot
Scaffold mining of kinase hinge binders in crystal structure database
inferred← citeshttps://doi.org/10.1007/s12032-017-1011-5openalex-snapshot
Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1
inferred← citeshttps://doi.org/10.1007/s13721-017-0162-9openalex-snapshot
Systems biology approach deciphering the biochemical signaling pathway and pharmacokinetic study of PI3K/mTOR/p53-Mdm2 module involved in neoplastic transformation
inferred← citeshttps://doi.org/10.1016/b978-0-12-397918-6.00002-1openalex-snapshot
A Structural Atlas of Kinases Inhibited by Clinically Approved Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-397918-6.00005-7openalex-snapshot
The Resistance Tetrad
inferred← citeshttps://doi.org/10.1016/b978-0-12-411492-0.00028-6openalex-snapshot
Antineoplastic Agents
inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00012-2openalex-snapshot
Omics-Driven Knowledge-Based Discovery of Anthelmintic Targets and Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-819668-7.00002-6openalex-snapshot
A ligand-centric approach to identify potential drugs for repurposing
inferred← citeshttps://doi.org/10.1016/b978-0-12-822312-3.00009-6openalex-snapshot
Design and Discovery of Kinase Inhibitors Using Docking Studies
inferred← citeshttps://doi.org/10.1016/bs.aihch.2015.10.004openalex-snapshot
Phosphono- and Phosphinolactones in the Life Sciences
inferred← citeshttps://doi.org/10.1016/j.ab.2013.11.023openalex-snapshot
A versatile spectrophotometric protein tyrosine phosphatase assay based on 3-nitrophosphotyrosine containing substrates
inferred← citeshttps://doi.org/10.1016/j.ab.2014.01.007openalex-snapshot
A continuous and direct assay to monitor leucine-rich repeat kinase 2 activity
inferred← citeshttps://doi.org/10.1016/j.ab.2015.11.007openalex-snapshot
Bioluminescent kinase strips: A novel approach to targeted and flexible kinase inhibitor profiling
inferred← citeshttps://doi.org/10.1016/j.ab.2017.06.001openalex-snapshot
Characterization of PKACα enzyme kinetics and inhibition in an HPLC assay with a chromophoric substrate
inferred← citeshttps://doi.org/10.1016/j.aca.2015.07.058openalex-snapshot
A real-time, fluorescence-based assay for Rho-associated protein kinase activity
inferred← citeshttps://doi.org/10.1016/j.aca.2015.09.025openalex-snapshot
Design and evaluation of a real-time activity probe for focal adhesion kinase
inferred← citeshttps://doi.org/10.1016/j.ailsci.2023.100079openalex-snapshot
An industrial evaluation of proteochemometric modelling: Predicting drug-target affinities for kinases
inferred← citeshttps://doi.org/10.1016/j.bbapap.2013.02.039openalex-snapshot
Responsive microsecond-lifetime photoluminescent probes for analysis of protein kinases and their inhibitors
inferred← citeshttps://doi.org/10.1016/j.bbrc.2013.09.028openalex-snapshot
Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma
inferred← citeshttps://doi.org/10.1016/j.bbrep.2024.101767openalex-snapshot
In silico identification of putative druggable pockets in PRL3, a significant oncology target
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120536openalex-snapshot
Receptor tyrosine kinases-instructed release of its inhibitor from hydrogel to delay ovarian aging
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103035openalex-snapshot
Design, synthesis and anticervical cancer activity of new benzofuran–pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.103624openalex-snapshot
Binding patterns and structure–activity relationship of CDK8 inhibitors
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2015.05.006openalex-snapshot
Panel docking of small-molecule libraries — Prospects to improve efficiency of lead compound discovery
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2015.08.001openalex-snapshot
Discovery and resupply of pharmacologically active plant-derived natural products: A review
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2018.02.013openalex-snapshot
Advances in kinome research of parasitic worms - implications for fundamental research and applied biotechnological outcomes
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.11.029openalex-snapshot
The generality of kinase-catalyzed biotinylation
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.02.055openalex-snapshot
Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.08.037openalex-snapshot
Design, synthesis, and biological evaluation of novel 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives as potent receptor tyrosine kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2026.130680openalex-snapshot
Discovery of GSI526: a potent IRAK4-targeting PROTAC degrader with efficient degradation and suppression of inflammatory signaling
inferred← citeshttps://doi.org/10.1016/j.bone.2020.115472openalex-snapshot
Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.cbpa.2017.06.015openalex-snapshot
Advances of small molecule targeting of kinases
inferred← citeshttps://doi.org/10.1016/j.cbpa.2018.11.001openalex-snapshot
Regulation of phagosome functions by post-translational modifications: a new paradigm
inferred← citeshttps://doi.org/10.1016/j.cbpa.2019.02.022openalex-snapshot
Targeted protein degradation: elements of PROTAC design
inferred← citeshttps://doi.org/10.1016/j.cbpc.2017.11.001openalex-snapshot
Developmental effects of the protein kinase inhibitor kenpaullone on the sea urchin embryo
inferred← citeshttps://doi.org/10.1016/j.ccell.2016.01.006openalex-snapshot
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
inferred← citeshttps://doi.org/10.1016/j.cels.2018.07.001openalex-snapshot
Coral: Clear and Customizable Visualization of Human Kinome Data
inferred← citeshttps://doi.org/10.1016/j.chembiol.2014.02.016openalex-snapshot
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases
inferred← citeshttps://doi.org/10.1016/j.chembiol.2016.07.017openalex-snapshot
Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2022.107712openalex-snapshot
Catalytic activity in vitro of the human protein kinase ASK1 mutants: Experimental and molecular simulation study
inferred← citeshttps://doi.org/10.1016/j.cpan.2025.05.002openalex-snapshot
Exploring antiproliferative potential, in silico docking, and molecular dynamics of pyrimidine-morpholine hybrid molecules
inferred← citeshttps://doi.org/10.1016/j.cplett.2017.02.049openalex-snapshot
Improved treatment of nucleosides and nucleotides in the OPLS-AA force field
inferred← citeshttps://doi.org/10.1016/j.ddtec.2015.10.007openalex-snapshot
Protein kinase profiling assays: a technology review
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.01.018openalex-snapshot
An innovative kinome platform to accelerate small-molecule inhibitor discovery and optimization from hits to leads
inferred← citeshttps://doi.org/10.1016/j.dscb.2025.100193openalex-snapshot
Tyrosine kinase as therapeutic target of neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.ejmech.2013.10.037openalex-snapshot
New aminopyrimidine derivatives as inhibitors of the TAM family
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.112openalex-snapshot
1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.10.003openalex-snapshot
Fluorescent biosensors for drug discovery new tools for old targets – Screening for inhibitors of cyclin-dependent kinases
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.02.051openalex-snapshot
A facile synthesis and microtubule-destabilizing properties of 4-(1H-benzo[d]imidazol-2-yl)-furazan-3-amines
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.11.012openalex-snapshot
Extended structure–activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111833openalex-snapshot
Antiproliferative activity and mode of action analysis of novel amino and amido substituted phenantrene and naphtho[2,1-b]thiophene derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113620openalex-snapshot
Discovery of novel 2,3,5-trisubstituted pyridine analogs as potent inhibitors of IL-1β via modulation of the p38 MAPK signaling pathway
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115761openalex-snapshot
Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.01.045openalex-snapshot
Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock
inferred← citeshttps://doi.org/10.1016/j.elecom.2015.05.014openalex-snapshot
Multimodal electrochemical and nanoplasmonic biosensors using ferrocene-crowned nanoparticles for kinase drug discovery applications
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2019.06.158openalex-snapshot
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
inferred← citeshttps://doi.org/10.1016/j.ijpara.2014.06.005openalex-snapshot
Bioinformatic exploration of RIO protein kinases of parasitic and free-living nematodes
inferred← citeshttps://doi.org/10.1016/j.it.2019.07.001openalex-snapshot
ABIN-2, of the TPL-2 Signaling Complex, Modulates Mammalian Inflammation
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102247openalex-snapshot
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
inferred← citeshttps://doi.org/10.1016/j.jmb.2016.12.019openalex-snapshot
Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance
inferred← citeshttps://doi.org/10.1016/j.jmb.2017.05.014openalex-snapshot
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity
inferred← citeshttps://doi.org/10.1016/j.jmgm.2017.01.014openalex-snapshot
Multi-step virtual screening to develop selective DYRK1A inhibitors
inferred← citeshttps://doi.org/10.1016/j.mbplus.2022.100108openalex-snapshot
Small molecule inhibitors of mammalian glycosylation
inferred← citeshttps://doi.org/10.1016/j.mbs.2015.01.010openalex-snapshot
Bioinformatics in protein kinases regulatory network and drug discovery
inferred← citeshttps://doi.org/10.1016/j.molmet.2016.08.008openalex-snapshot
TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
inferred← citeshttps://doi.org/10.1016/j.molstruc.2019.05.024openalex-snapshot
N,N′-diaryl urea derivatives: Molecular docking, molecular properties prediction and anticancer evaluation
inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.132674openalex-snapshot
Development of penipanoid C-inspired 2-benzoyl-1-methyl-2,3-dihydroquinazolin-4(1H)-one derivatives as potential EGFR inhibitors: Synthesis, anticancer evaluation and molecular docking study
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.01.003openalex-snapshot
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.07.010openalex-snapshot
A historical overview of protein kinases and their targeted small molecule inhibitors
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.10.021openalex-snapshot
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
inferred← citeshttps://doi.org/10.1016/j.phrs.2016.07.038openalex-snapshot
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.04.022openalex-snapshot
ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.12.021openalex-snapshot
Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers
inferred← citeshttps://doi.org/10.1016/j.phrs.2018.01.021openalex-snapshot
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
inferred← citeshttps://doi.org/10.1016/j.phrs.2019.01.039openalex-snapshot
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
inferred← citeshttps://doi.org/10.1016/j.phrs.2019.03.006openalex-snapshot
Properties of FDA-approved small molecule protein kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.105660openalex-snapshot
Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymes
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2017.12.006openalex-snapshot
Kinases in synaptic development and neurological diseases
inferred← citeshttps://doi.org/10.1016/j.rechem.2026.103605openalex-snapshot
An integrated machine learning–guided molecular modeling approach for the identification of GSK-3β inhibitors
inferred← citeshttps://doi.org/10.1016/j.tetlet.2016.11.047openalex-snapshot
The synthesis of novel pyrrololactams and their boronate ester derivatives
inferred← citeshttps://doi.org/10.1016/j.tips.2015.08.013openalex-snapshot
Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy
inferred← citeshttps://doi.org/10.1016/j.toxlet.2019.05.005openalex-snapshot
Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach
inferred← citeshttps://doi.org/10.1021/acs.accounts.6b00537openalex-snapshot
Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases
inferred← citeshttps://doi.org/10.1021/acs.analchem.5b01160openalex-snapshot
Phosphorylation-Mediated Assembly of a Semisynthetic Fluorescent Protein for Label-Free Detection of Protein Kinase Activity
inferred← citeshttps://doi.org/10.1021/acs.biochem.6b00629openalex-snapshot
Chemoproteomic Evaluation of Target Engagement by the Cyclin-Dependent Kinase 4 and 6 Inhibitor Palbociclib Correlates with Cancer Cell Response
inferred← citeshttps://doi.org/10.1021/acs.biochem.7b00521openalex-snapshot
Discovery of Inactive Conformation-Selective Kinase Inhibitors by Utilizing Cascade Assays
inferred← citeshttps://doi.org/10.1021/acs.chemrev.7b00105openalex-snapshot
Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00839openalex-snapshot
KinFragLib: Exploring the Kinase Inhibitor Space Using Subpocket-Focused Fragmentation and Recombination
inferred← citeshttps://doi.org/10.1021/acs.jcim.1c00608openalex-snapshot
Kinase Inhibitor Scaffold Hopping with Deep Learning Approaches
inferred← citeshttps://doi.org/10.1021/acs.jcim.1c00889openalex-snapshot
Active Site Sequence Representations of Human Kinases Outperform Full Sequence Representations for Affinity Prediction and Inhibitor Generation: 3D Effects in a 1D Model
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00050openalex-snapshot
KiSSim: Predicting Off-Targets from Structural Similarities in the Kinome
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00595openalex-snapshot
The Development and Application of KinomePro-DL: A Deep Learning Based Online Small Molecule Kinome Selectivity Profiling Prediction Platform
inferred← citeshttps://doi.org/10.1021/acs.jcim.6b00122openalex-snapshot
Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00684openalex-snapshot
Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jctc.2c01171openalex-snapshot
Strategy toward Kinase-Selective Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00055openalex-snapshot
Identification of N-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives as Novel, Potent, and Selective NF-κB Inducing Kinase (NIK) Inhibitors for the Treatment of Psoriasis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00249openalex-snapshot
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01511openalex-snapshot
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01165openalex-snapshot
Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c03006openalex-snapshot
Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00993openalex-snapshot
Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01346openalex-snapshot
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01611openalex-snapshot
Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00667openalex-snapshot
Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00443openalex-snapshot
Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)
inferred← citeshttps://doi.org/10.1021/acs.jpcb.1c00016openalex-snapshot
Rapid Identification of Inhibitors and Prediction of Ligand Selectivity for Multiple Proteins: Application to Protein Kinases
inferred← citeshttps://doi.org/10.1021/acs.jproteome.5b00161openalex-snapshot
Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition
inferred← citeshttps://doi.org/10.1021/acs.jproteome.8b00062openalex-snapshot
Characterization of Plasmodium falciparum Atypical Kinase PfPK7– Dependent Phosphoproteome
inferred← citeshttps://doi.org/10.1021/acs.jproteome.8b00883openalex-snapshot
Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate
inferred← citeshttps://doi.org/10.1021/acs.jproteome.8b00942openalex-snapshot
Identification of the Direct Substrates of the ABL Kinase via Kinase Assay Linked Phosphoproteomics with Multiple Drug Treatments
inferred← citeshttps://doi.org/10.1021/acs.jproteome.9b00742openalex-snapshot
Kinobead/LC-MS Phosphokinome Profiling Enables Rapid Analyses of Kinase-Dependent Cell Signaling Networks
inferred← citeshttps://doi.org/10.1021/acsabm.8b00451openalex-snapshot
Reduced Graphene Oxide-Zirconium Dioxide–Thionine Nanocomposite Integrating Recognition, Amplification, and Signaling for an Electrochemical Assay of Protein Kinase Activity and Inhibitor Screening
inferred← citeshttps://doi.org/10.1021/acscentsci.7b00486openalex-snapshot
Glutathione-Responsive Selenosulfide Prodrugs as a Platform Strategy for Potent and Selective Mechanism-Based Inhibition of Protein Tyrosine Phosphatases
inferred← citeshttps://doi.org/10.1021/acschembio.5b01063openalex-snapshot
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
inferred← citeshttps://doi.org/10.1021/acschembio.6b00511openalex-snapshot
Discovery and Characterization of Allosteric WNK Kinase Inhibitors
inferred← citeshttps://doi.org/10.1021/acschembio.6b00827openalex-snapshot
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.5b00118openalex-snapshot
Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.5b00167openalex-snapshot
Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.7b00296openalex-snapshot
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00445openalex-snapshot
Evolution of Small Molecule Kinase Drugs
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.9b00027openalex-snapshot
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00023openalex-snapshot
Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration
inferred← citeshttps://doi.org/10.1021/cb300655wopenalex-snapshot
Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor
inferred← citeshttps://doi.org/10.1021/cb300709gopenalex-snapshot
Cell-Penetrating Bisubstrate-Based Protein Kinase C Inhibitors
inferred← citeshttps://doi.org/10.1021/cb300729yopenalex-snapshot
De Novo Design of Protein Kinase Inhibitors by in Silico Identification of Hinge Region-Binding Fragments
inferred← citeshttps://doi.org/10.1021/cb400013topenalex-snapshot
Chemical Biology – Current and Next Challenges
inferred← citeshttps://doi.org/10.1021/cb400407copenalex-snapshot
Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
inferred← citeshttps://doi.org/10.1021/cb5002125openalex-snapshot
ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling
inferred← citeshttps://doi.org/10.1021/cb500355copenalex-snapshot
Discovery of Inter-Domain Stabilizers—A Novel Assay System for Allosteric Akt Inhibitors
inferred← citeshttps://doi.org/10.1021/ja4030484openalex-snapshot
Selective Detection of Allosteric Phosphatase Inhibitors
inferred← citeshttps://doi.org/10.1021/jacs.8b10160openalex-snapshot
Identification of Kinases and Interactors of p53 Using Kinase-Catalyzed Cross-Linking and Immunoprecipitation
inferred← citeshttps://doi.org/10.1021/jacs.9b08660openalex-snapshot
Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology
inferred← citeshttps://doi.org/10.1021/jm400248copenalex-snapshot
A Potent and Selective Small-Molecule Inhibitor for the Lymphoid-Specific Tyrosine Phosphatase (LYP), a Target Associated with Autoimmune Diseases
inferred← citeshttps://doi.org/10.1021/jm401742ropenalex-snapshot
Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
inferred← citeshttps://doi.org/10.1021/jm5006176openalex-snapshot
Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
inferred← citeshttps://doi.org/10.1021/jm501038sopenalex-snapshot
Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors
inferred← citeshttps://doi.org/10.1021/ml500071mopenalex-snapshot
New Frontiers in Kinases: Special Issue
inferred← citeshttps://doi.org/10.1021/ml500091popenalex-snapshot
A New Challenging and Promising Era of Tyrosine Kinase Inhibitors
inferred← citeshttps://doi.org/10.1021/pr400455jopenalex-snapshot
Characterization of a Chemical Affinity Probe Targeting Akt Kinases
inferred← citeshttps://doi.org/10.1038/aps.2014.80openalex-snapshot
Protein tyrosine phosphatases as potential therapeutic targets
showing the first 200 of 371 · page through all 371
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.